Melanotan 2 research guide for Srch. Melanocortin agonist studied for tanning and libido — covers purity testing, COA verification, reconstitution, and sourcing.
Unlike general health products stocked in every health store, Melanotan 2 reaches researchers through a global research peptide market that Srch residents navigate through international suppliers. This online-only market structure is a genuine benefit for researchers — top vendors compete on lab-verified purity in ways brick-and-mortar outlets simply cannot. Separating properly characterised Melanotan 2 from the rest of the market requires three things: an HPLC chromatogram showing ≥98% purity, mass spec data establishing the correct molecular weight, and a batch-specific endotoxin panel. Use this guide to assess sourcing options methodically — the quality evaluation approach outlined here work regardless of your location.
How Melanotan 2 Works — Mechanisms & Research
The melanocortin receptor family (MC1R through MC5R) mediates a diverse range of physiological functions, and research peptides like Melanotan-2 and PT-141 (Bremelanotide) act on different receptor subtypes with different research applications. MT-2 has broad melanocortin receptor activity and has been studied for pigmentation (MC1R), appetite suppression (MC4R), and other endpoints. PT-141 is a more specific MC3R/MC4R agonist studied primarily for CNS-mediated effects. For researchers in Srch designing experiments with Melanotan 2, the specific receptor binding profile determines which outcomes are mechanistically attributable to the compound and which require additional explanation.
How to Source Melanotan 2 — Vendor Guide
Before evaluating any specific vendor, build a clear picture of what a proper COA looks like — so you can recognise whether a vendor meets it. Mass spectrometry in the COA confirms that the main HPLC peak is actually Melanotan 2 and not a structurally similar impurity — HPLC purity alone cannot verify molecular identity. Positive vendor signals beyond COA quality: established track record of at least two years, customer service that can discuss analytical methods, and cold chain packaging that protects product integrity. For Srch researchers making a first Melanotan 2 purchase: work through this evaluation framework first, order conservatively at first, and verify batch traceability on arrival before use.
Order Melanotan 2 — ships to Srch
COA-verified · International tracking · Research grade
As a research compound, Melanotan 2 has not been through the clinical trial process required for pharmaceutical approval — its safety profile is based on preclinical research and limited human studies. Lyophilised Melanotan 2 should be placed in the freezer at −20°C straight away; do not freeze and thaw reconstituted Melanotan 2 multiple times by preparing small aliquots before storage. Quality Melanotan 2 sourcing directly determines safety outcomes — bacterial endotoxin contamination, incorrect identity, and breakdown products are all safety issues that proper COA verification addresses. For any individual considering Melanotan 2 outside a formal research context: speak with a healthcare professional — this compound is not a licensed human medication and its known risks are not comparable to approved pharmaceuticals.
Frequently Asked Questions
How is Melanotan-2 stored?
Lyophilized MT-2 should be stored at −20°C away from light (UV degrades the peptide). Once reconstituted, it should be kept refrigerated at 2-8°C in an amber or light-protected vial, and used within 30 days. MT-2 is sensitive to UV exposure, so minimize light contact during reconstitution and handling.
What is Melanotan-2?
Melanotan-2 (MT-2) is a cyclic analogue of alpha-melanocyte-stimulating hormone (α-MSH) with modifications that increase potency and half-life compared to native α-MSH. It acts on multiple melanocortin receptors including MC1R (pigmentation), MC3R and MC4R (CNS effects). It is a research compound studied for melanocortin receptor pharmacology.
What are the main receptor targets of Melanotan-2?
MT-2 is a relatively non-selective melanocortin receptor agonist with activity at MC1R (melanocyte pigmentation stimulation), MC3R (CNS, energy homeostasis), MC4R (CNS, appetite/libido-related effects), and some activity at MC5R. This broad receptor activity profile means it has multiple simultaneous effects in research models.
